A Rare Case of Anti Phospholipid Syndrome Associated Intermediate and Posterior Uveitis
Ophthalmology Research: An International Journal,
Introduction: Autoimmune disorders are often associated with Uveitis. Anti-Phospholipid syndrome(APS) is characterized by increased hypercoagulability and divergent ocular features.
Case Presentation: A 45-year-old male patient presented with complaints of headache for 2 days. The patient gives a history of fever and loss of consciousness 20 days back and was treated symptomatically. On examination Visual acuity was 6/6 in the right eye and 6/12 in the left eye. On slit-lamp examination, the anterior segment was normal, vitreous cells were 2+ suggestive of vitritis in the left eye. Dilated fundus examination showed exudates in both eyes with macular parafoveal edema in the left eye. Laboratory investigations showed Antiphospholipid Antibody Immunoglobulin M (IgM) and Beta 2 glycoprotein IgM positive and raised ESR, PTT, and triglycerides. MRI brain showed acute embolic infarcts in multiple areas.
Management: Topical Steroids and cycloplegic for uveitis and systemic steroids and anticoagulants for systemic manifestations were given and the patient's vision improved to 6/6 and macular edema reduced in the left eye during the follow-up.
Conclusion: APS is a life and vision-threatening multisystem disorder, needs monitoring for INR and Anti phospholipid antibodies. A rare manifestation of uveitis is noted and prompt treatment with topical, oral steroids resolves the uveitis. But to prevent recurrences and further thrombotic events long-term immunosuppression, anticoagulation treatment is required.
- APS-antiphospholipid syndrome
- APL antibodies- antiphospholipid antibodies
- IgM- immunoglobulin M
How to Cite
Grossman JM. Primary versus secondary antiphospholipid syndrome: Is this lupus or not? Curr Rheumatol Rep. 2004;6(6):445-50.
DOI:10.1007/s11926-004-0023-2. PMID: 15527703.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
DOI:10.1111/j.1538-7836.2006.01753.x. PMID: 16420554.
Khamashta MA, Bertolaccini ML, Hughes GR. Antiphospholipid (Hughes) syndrome. Autoimmunity. 2004;37(4):309-12.
DOI:10.1080/08916930410001708706. PMID: 15518048.
Tsironi E, Gatselis N, Kotoula MG, et al. Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: A case series. Cases Journal. 2009;2:159.
Allam RS, Ali BM. Hypertensive uveitis: An initial presentation for primary antiphospholipid syndrome. Delta J Ophthalmol [serial online]. 2017;18:185-9.
[cited 2021 Jun 29].
Takkar B, Khokhar S, Kumar U, Venkatesh P. Necrotising scleritis, keratitis and uveitis in primary antiphospholipid syndrome. BMJ Case Rep. 2018. bcr2017220647.
DOI:10.1136/bcr-2017-220647. PMID: 29764818; PMCID: PMC5961539.
Abstract View: 61 times
PDF Download: 27 times